Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Keyphrases

• Continuous Infusion 100%
• Von Willebrand Disease 100%
• Von Willebrand Factor Concentrate 100%
• Von Willebrand Factor 50%
• Intravenous Immunoglobulin (IVIg) 37%
• Bolus Dosing 37%
• Monoclonal Gammopathy of Undetermined Significance 37%
• Intermittent Bolus 25%
• Bleeding 12%
• Treatment Effect 12%
• Lack of Response 12%
• In(III) 12%
• Most Common Cause 12%
• Disease-associated 12%
• Immunoglobulin G 12%
• Lymphoproliferative Disorders 12%
• Hemostasis 12%
• Peak Response 12%
• Bleeding Risk 12%
• Rare Disorders 12%
• Bleeding Patients 12%
• Factor Replacement 12%
• Ristocetin Cofactor 12%

Medicine and Dentistry

• Von Willebrand Factor 100%
• Continuous Infusion 100%
• Von Willebrand Disease 100%
• Immunoglobulin 30%
• Monoclonal Gammopathy of Undetermined Significance 30%
• Treatment Effect 10%
• Blood Stasis 10%
• Immunoglobulin G 10%
• Orphan Disorder 10%
• Ristocetin 10%
• Lymphoproliferative Disease 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Von Willebrand Factor 100%
• Von Willebrand Disease 100%
• Immunoglobulin 30%
• Monoclonal Immunoglobulinemia 30%
• Disease 10%
• Blood Stasis 10%
• Immunoglobulin G 10%
• Ristocetin 10%
• Lymphoproliferative Disease 10%